The San Joaquin Valley CCOP (SJV CCOP) is an established and recognized program structured to provide the latest methods for prevention, diagnosis and treatment to the cancer patient in the community. Through an experienced multidisciplinary consortium and affiliations with research bases approved by the National Cancer Institute, the SJV CCOP will continue to meet the goals for increased patient accrual to treatment and cancer control clinical trials. The SJV CCOP will continue its excellent accrual rate with its established research bases, Northern California Cancer Program (NCCP), National Surgical Adjuvant Breast and Bowel Project (NSABP), and Radiation Therapy Oncology Group (RTOG), increase its accrual through a new affiliation with Southwest Oncology Group (SWOG), and assume responsibility for community research with Childrens Cancer Study Group (CCSG). The SJV CCOP will encourage increased participation by selecting appropriate protocols, maintaining group-wide communication and promoting physician involvement in research base activities. The SJV CCOP will expand to implement cancer control clinical trials developed by its research bases. Cancer control studies will be selected based on feasibility, availability of resources and the identification of interested allied health workers. The SJV CCOP will work with health departments and the state-mandated Regional Tumor Registry to develop cancer control projects which are important to the San Joaquin Valley. The SJV CCOP will pursue improved methods for data collection and quality control. The SJV CCOP will computerize its tracking system for patients, protocols and data collection. The SJV CCOP will work with the research bases to implement consistent reporting requirements and will begin testing a computer-based protocol management system developed by NCCP. The SJV CCOP will further integrate its position as a health resource in the community. Consultation to hospital cancer programs, institutional review boards and the Regional Tumor Registry will continue to be provided. Education opportunities for the medical and lay community will also be supported. Accomplishing these stated aims will demonstrate the important role that the SJV CCOP plays in bringing state-of-the-art cancer prevention and treatment methods to the community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA035283-05
Application #
3557720
Study Section
(SRC)
Project Start
1983-09-30
Project End
1990-05-31
Budget Start
1988-09-01
Budget End
1989-05-31
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Fresno Community Hospital & Medical Center
Department
Type
DUNS #
City
Fresno
State
CA
Country
United States
Zip Code
93721
Tangen, Catherine M; Hussain, Maha H A; Higano, Celestia S et al. (2012) Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). J Urol 188:1164-9
Albain, Kathy S; Barlow, William E; Shak, Steven et al. (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 11:55-65
Albain, Kathy S; Barlow, William E; Ravdin, Peter M et al. (2009) Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial. Lancet 374:2055-63
Beer, Tomasz M; Tangen, Catherine M; Bland, Lisa B et al. (2006) The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894. Cancer 107:489-96
John, M; Flam, M; Sikic, B et al. (1990) Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study. Gynecol Oncol 37:1-5
Carlson, R W; Borrison, R A; Sher, H B et al. (1990) A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain. Pharmacotherapy 10:211-6
John, M J; Flam, M S; Mowry, P A et al. (1989) Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 63:2397-403
John, M J; Flam, M S; Mowry, P A (1988) Clinical potential of synchronous radiotherapy and chemotherapy for advanced squamous cell carcinoma. NCI Monogr :375-8
John, M J; Flam, M; Lovalvo, L et al. (1987) Feasibility of non-surgical definitive management of anal canal carcinoma. Int J Radiat Oncol Biol Phys 13:299-303
John, M; Cooke, J K; Flam, M et al. (1987) Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma. Gynecol Oncol 28:101-10

Showing the most recent 10 out of 11 publications